Psorimed

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Psorimed

What is Psorimed?

Psorimed is a topical medication formulated as a solution for application to the skin or scalp. It belongs to a class of drugs known as corticosteroids, specifically containing the active ingredient clobetasol propionate. This substance is classified as a very high-potency topical corticosteroid designed to manage specific dermatological conditions.

Therapeutic Purpose

The primary function of Psorimed is to reduce the physical symptoms associated with inflammatory skin disorders. It works by suppressing the immune response in the localized area where it is applied. This action helps to decrease the production of inflammatory chemicals in the body, which are responsible for the redness, swelling, and itching characteristic of various skin conditions.

Conditions Treated

Psorimed is primarily used for the treatment of resistant skin diseases that have not responded sufficiently to less potent corticosteroids. Common conditions for which this medication may be utilized include:

  • Psoriasis: A chronic autoimmune condition that causes the rapid buildup of skin cells, leading to scaling and inflammation.
  • Recalcitrant Eczemas: Severe forms of dermatitis that cause itchy, inflamed, and cracked skin.
  • Lichen Planus: An inflammatory condition that affects the skin and mucous membranes, often appearing as purple, itchy, flat-topped bumps.
  • Discoid Lupus Erythematosus: A chronic skin condition characterized by inflammation and scarring-type red patches, usually on the face, scalp, and ears.

Because of its high potency, Psorimed is typically reserved for short-term use to bring acute flare-ups under control or to treat thick, hyperkeratotic lesions that are difficult to penetrate with milder topical agents.

Regulatory References

  1. Sodium Salicylate
  2. Nonsteroidal Anti-inflammatory Drug (NSAID)
  3. Analgesic
  4. Antipyretic
  5. salicylates
  6. solution
  7. liquid formulation
  8. base/vehicle
  9. topical application
  10. salicylate salts
  11. fever
  12. pain
  13. inflammation

What side effects are possible with Psorimed?

Safety Profile Overview

Psorimed's safety profile is primarily characterized by the risk of systemic toxicity due to the percutaneous absorption of its active ingredient, salicylic acid, particularly with high doses, prolonged use, or when applied to large or compromised skin areas. The regulatory framework emphasizes strict adherence to dose limits and contraindications to mitigate this risk.


Adverse Reactions and Safety Restrictions

Key Systemic Risk

The main safety concern is the potential for systemic effects, especially in patients with reduced renal capacity or hepatic insufficiency, which are formal contraindications. The maximum daily adult dose of 2 grams of salicylic acid must not be exceeded, and treatment duration should not be longer than one week to prevent systemic accumulation.

Contraindications and Cautions

Category Restrictions/Considerations
Patient Groups Contraindicated in neonates, infants, children under 12 years, and during the third trimester of pregnancy (due to systemic risk). Caution is required for the elderly.
Application Contraindicated for unstable and acute inflammatory forms of psoriasis. The product must not be used concurrently with other topical treatments on the scalp, as salicylic acid may enhance the absorption of other medications.
Local Effects Local irritation is possible, often linked to excipients like propylene glycol. Contact with eyes, nose, mucous membranes, and healthy skin must be strictly avoided.

Regulatory Summary

The regulatory summary explicitly warns against use in conditions that increase the risk of systemic absorption (renal/hepatic impairment). The safety structure ensures that the product is limited to the initial treatment of mild to moderately severe psoriasis of the scalp, thereby controlling the overall risk exposure.

Overdose and Emergency Response

Regulatory information for Psorimed (Sodium Salicylate) overdose centers on recognizing the acute state of salicylate toxicity, officially known as Salicylism. Documented manifestations include sensory effects such as tinnitus (ringing in the ears) and deafness, along with gastrointestinal distress (nausea/vomiting), sweating, and key respiratory changes like hyperpnea (deep and rapid breathing). The underlying physiological concern is a progressive disturbance in the body’s acid-base balance, typically moving toward a severe metabolic acidosis. Potential for increased severity is noted in susceptible populations, including children and the elderly.

Overdose may escalate rapidly into life-threatening scenarios. Documented severe outcomes include central nervous system complications such as seizures and coma, as well as cerebral edema (brain swelling) and pulmonary edema (fluid in the lungs). Cardiovascular collapse and refractory acidaemia are also officially listed as critical complications.

Seek immediate medical attention for any suspected overdose or known ingestion of a toxic amount (generally ge 150 mg/kg). This official mandate requires immediate contact with emergency services or a Poison Control Center. Management is explicitly supportive, as no specific antidote is known. Treatment procedures documented in official regulatory labels include enhanced elimination techniques such as urinary alkalinization or, in severe cases, haemodialysis. Close monitoring of plasma concentration and acid-base status is required.

Therapeutic Uses of Psorimed

What Psorimed Treats: Main Uses and Benefits

Psorimed, containing the therapeutic compound Sodium Salicylate, is used across domains where additional symptomatic support is needed. The substance is generally classified for its core therapeutic use for easing pain and helping manage fever. The medicine is relevant for managing symptoms related to systemic imbalance and inflammatory or irritative states, and is considered relevant in conditions characterized by periods of heightened symptoms. It is commonly applied in addressing both musculoskeletal pain and inflammation, such as that associated with osteoarthritis or minor soft tissue injuries, and systemic symptoms including elevated body temperature. This approach to symptom management supports the patient during difficult episodes, which may assist with maintaining comfort. The compound is considered relevant for providing supportive relief when symptoms interfere with routine activities.


Quick Fact: Relief for Pain and Inflammation

Psorimed helps address symptom clusters that may become intense or disruptive, such as localized pain and swelling that interfere with daily functioning. This use may assist with maintaining functional stability during symptomatic periods.

Regulatory References

  1. NIH MeSH overview

Eligibility and Restrictions for Use

Official Population Eligibility for Psorimed

The official eligibility profile for Psorimed, an NSAID containing Sodium Salicylate, is defined by absolute regulatory exclusions and conditional use guidelines, as documented in government labeling.

Contraindications

Use of Psorimed is strictly contraindicated for several populations:

  • Patients with documented hypersensitivity to Sodium Salicylate, aspirin, or any other Nonsteroidal Anti-inflammatory Drug (NSAID).
  • Individuals, especially children and teenagers, who have or are recovering from flu or chickenpox symptoms (due to the labeled risk of Reye's Syndrome).
  • Women at 30 weeks gestation and later in pregnancy.
  • Patients experiencing peri-operative pain in the setting of Coronary Artery Bypass Graft (CABG) surgery.

Conditional Eligibility and Restrictions

Eligibility requires caution or is restricted in several other groups:

  • Gestational Eligibility: Use is restricted between 20 and 30 weeks gestation. Breastfeeding women are advised to seek alternatives, and if used topically, application to the breast area is not recommended.
  • Organ Function: Caution is required for patients with impaired renal function, hepatic impairment, or cardiovascular conditions (e.g., heart failure or hypertension).
  • Age-Specific Rules: Use in children under 6 years for self-medication is generally not recommended, and topical use is contraindicated in children under 2 years of age.
  • Comorbidities: The label requires caution for elderly patients and individuals with a history of gastrointestinal problems or active bleeding disorders.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documents define the interaction profile of Psorimed (Sodium Salicylate) based on pharmacokinetic and pharmacodynamic patterns. Co-administration with other high-dose Nonsteroidal Anti-inflammatory Drugs (NSAIDs) or Salicylates is contraindicated due to a documented high risk of adverse effects, primarily hemorrhage.

Pharmacokinetic and Elimination Interactions

Psorimed may interfere with the elimination of certain co-administered drugs. Regulatory labels state that Sodium Salicylate reduces the renal clearance of Methotrexate, leading to increased plasma concentrations of Methotrexate. Similarly, it may interfere with the renal tubular secretion of Penicillin. Psorimed also causes protein binding displacement of agents like Valproic Acid, resulting in increased unbound Valproate plasma levels and a heightened risk of toxicity.

Pharmacodynamic and Substance Interactions

Co-administration with Oral Anticoagulants (e.g., Warfarin) increases the risk of bleeding due to additive antiplatelet effects. This same elevated risk applies to co-use with Selective Serotonin Reuptake Inhibitors (SSRIs) and certain Herbal Products (e.g., Ginkgo biloba). Furthermore, Psorimed may inhibit the effect of Uricosuric Agents and may reduce the efficacy of some Diuretics like Spironolactone. Consumption of Alcohol increases the specific risk of gastrointestinal hemorrhage.

Mechanism of Action

️ How Psorimed Works: Mechanistic Domains

Psorimed, with its active component Sodium Salicylate, works by modulating key enzymatic and signaling pathways that govern inflammatory responses and central thermoregulation.


Regulation of the Eicosanoid Pathway and Nociceptive Signaling

The core mechanism involves the inhibition of Cyclooxygenase (COX) enzymes, particularly COX-2, which are central to the Arachidonic Acid Cascade. By blocking the enzyme's activity, the drug reduces the production of prostaglandins (PGE2). This reduction attenuates the chemical sensitization of peripheral pain receptors, resulting in decreased signal transmission.


Central Thermoregulatory Resetting

A distinct part of the mechanism occurs in the central nervous system, where the drug limits prostaglandin synthesis within the hypothalamus. This targeted action facilitates the resetting of the body's elevated temperature set point. This physiological adjustment facilitates an internal process of heat dissipation, a consequence of the set point normalization.


Suppression of Inflammatory Gene Expression

Beyond immediate enzyme inhibition, the active ingredient is also known to modulate key regulatory proteins, such as the transcription factor NF-κB. This mechanism suppresses the genetic expression of various pro-inflammatory mediators and cytokines. This mechanism results in the limitation of downstream chemical mediator production that characterizes prolonged cellular inflammatory activation.

Dosage and Administration Information

Administration Scope: How Psorimed is Used

Psorimed, a liquid formulation containing the nonsteroidal anti-inflammatory drug (NSAID) Sodium Salicylate, is administered via two distinct pathways based on the intended effect. The product is used for topical application (external use only) for localized action, and it is also intended for oral intake for systemic analgesic and anti-inflammatory effects, depending on the specific concentration.

Standardized oral administration involves specific parameters regarding both the dose and the context of intake. For acute use in adults, doses range from 325 mg to 650 mg per dose, with repetition scheduled no more often than every four hours as needed. Oral doses are taken with food, milk, or a large volume of water to ensure appropriate local tolerability.

The duration of use for self-managed acute symptoms is limited, specifying that administration should not exceed 10 consecutive days. For chronic anti-inflammatory protocols, total daily doses are higher and are administered in divided doses under supervision. Furthermore, there is a constraint regarding the use of salicylate products in pediatric patients who are experiencing viral illnesses, such as varicella or influenza.

Instruction Classification Administration Requirement
Administration Method Oral / Topical (External Only)
Frequency Pattern As-Needed (Every 4 Hours) or Divided Daily Use
Use-Context Constraints Must be taken with food/water; Maximum 10 days for acute self-medication

Recent Clinical Evidence

Research Evidence / Overview of Studies for Psorimed

Evidence for Use in Musculoskeletal Pain and Inflammation

This section will summarize the types of high-quality research, such as randomized controlled trials and meta-analyses, that have been used in research exploring outcomes related to pain intensity and inflammation.

Research exploring Psorimed's active ingredient, Sodium Salicylate, often relies on Randomized Controlled Trials (RCTs) and comprehensive literature reviews. These studies were used in research exploring how symptoms change over time in adult populations in conditions such as osteoarthritis and soft tissue injuries. Studies monitored outcomes related to physical discomfort, primarily tracking patient-reported pain intensity. Findings describe patterns observed in the studies related to short-term measurements of pain intensity, and how the overall patient-assessed status evolved in certain groups. The overall evidence contributes to the broader evidence landscape for this established pharmacological class (NSAIDs).

Evidence for Use in Elevated Body Temperature (Fever)

This part will describe the established body of research, including foundational clinical trials, that investigated the physiological response related to temperature reduction and how the studies measured the core body temperature.

Research exploring Sodium Salicylate related to elevated body temperature, or fever, is well-established and primarily derived from foundational RCTs. Studies examined temporary physiological imbalance and measured outcomes related to systemic or functional imbalance, specifically tracking the measurements of core body temperature over defined time intervals. Studies show patterns related to the timeframe required for the onset of changes in temperature in febrile adults.

What is Still Uncertain About Psorimed

Evidence highlights what is known—and what is still uncertain—about Psorimed. Evidence quality varies across studies, particularly when reviewing older trials for specific formulations. Limited information for long-term outcomes is available, meaning the durability of any observed effects beyond several months is not fully established. Additionally, comparative evidence is lacking to provide clear insight into how the active ingredient compares to other therapies.

Key Studies & References

  1. Sodium Salicylate - MeSH Unique ID: D012980 (Pharmacologic actions and uses)

Frequently Asked Questions (FAQ)

Common questions about Psorimed (FAQ)

Q: What is the difference between Psorimed and other common psoriasis treatments?

A: Official documents classify Psorimed's active ingredient, Sodium Salicylate, as a Nonsteroidal Anti-inflammatory Drug (NSAID). This classification indicates it works by targeting the chemical pathways associated with pain and swelling. Its mechanism of action is distinct from other potential treatments for similar conditions, such as biologics or corticosteroids.


Q: What are the most commonly reported less serious side effects of Psorimed?

A: Regulatory documents indicate that common side effects for this drug class often involve the digestive system, and may include indigestion, nausea, and upper abdominal pain. Other effects that have been reported include headache or tinnitus (a ringing sound in the ears).


Q: Does Psorimed require any special blood tests or monitoring?

A: Regulatory information advises that some monitoring may be needed, particularly during the course of therapy. Monitoring of blood pressure is advised during the initiation and course of therapy. Additionally, labels advise monitoring for signs or symptoms of issues like anemia (low red blood cells) and hepatotoxicity (a condition affecting the liver).


Q: How does Psorimed affect the immune system?

A: The drug's mechanism is described in official documentation as modulating key regulatory proteins and suppressing the genetic expression of pro-inflammatory mediators and cytokines. This is a functional description of how the drug acts within the body's inflammatory response system.


Q: Is Psorimed known to interact with common vitamins or supplements?

A: Official warnings recommend caution regarding the use of the drug with certain herbal or vitamin supplements. The official product information suggests that individuals inform their healthcare provider about all supplements they are taking.


Q: What is the longest period Psorimed has been studied in clinical trials?

A: While the specific maximum duration of every trial is not listed, regulatory safety warnings are informed by research, including trials that have lasted up to approximately three years duration. Official information notes that risks associated with the drug class generally tend to increase with the duration of use.


Q: Do people usually take Psorimed for a short time or long-term?

A: Regulatory documents advise that the drug should be used for the shortest duration possible that achieves the treatment goals, using the lowest effective amount. For acute self-managed use, regulatory guidance states that administration should not exceed 10 consecutive days.


Q: What are the known potential interactions with common cold or flu medicines?

A: Official warnings caution against taking the medicine with other Nonsteroidal Anti-inflammatory Drugs (NSAIDs). Because many common cold and flu medicines contain NSAIDs or similar ingredients, their labels require caution due to the risk of additive effects.


Q: Do I need to change my diet while taking Psorimed?

A: Official instructions specify that oral doses must be taken with food, milk, or a large volume of water as a means to ensure appropriate local tolerability. There are no specific long-term diet changes broadly required by the primary regulatory label.


Q: How long does it typically take before I notice a difference with Psorimed?

A: Studies on the active ingredient, Salicylic Acid, show that it typically reaches its peak concentration in the blood within 1 to 2 hours after an oral dose. This information is related to the timing of the maximum concentration of the drug in the blood.


Q: Is Psorimed a permanent cure for the condition it treats?

A: Psorimed's active ingredient is classified as an analgesic (pain reliever) and anti-inflammatory agent. Its regulatory purpose is to provide symptomatic relief for pain, fever, and inflammation, and it is not described in official sources as a permanent cure for any condition.


Q: What should I do if I miss a dose of Psorimed?

A: General patient guidance suggests that individuals generally continue with their normal dosing schedule, taking the next dose at the regularly scheduled time. They are advised against taking a double dose to make up for a missed one.


Q: Are there any reports of Psorimed affecting sleep patterns?

A: While the regulatory label does not specifically or commonly list sleep pattern changes, some central nervous system (CNS) effects have been reported for this class of drug. These effects include general symptoms like confusion or irritability.


Q: Can Psorimed be used by people with a history of heart disease?

A: Official warnings indicate that NSAIDs may increase the risk of serious cardiovascular thrombotic events, such as heart attack and stroke. Regulatory documents advise that the drug requires caution in patients who have existing cardiovascular disease or related risk factors.


Q: Does Psorimed interact with alcohol?

A: Regulatory documents explicitly state that consumption of alcohol while taking the medicine increases the risk of gastrointestinal hemorrhage (stomach or intestinal bleeding). Official information suggests that the two should not be used together due to this specific, elevated risk.


Q: Are the initial side effects of Psorimed different from the long-term ones?

A: Regulatory documents distinguish between risks that can occur early in treatment, such as initial stomach irritation or bleeding, and those that increase with longer duration of use, such as serious GI events or renal papillary necrosis (a type of kidney damage).


Q: Does Psorimed help with joint pain as well as skin symptoms?

A: The active ingredient is indicated for the temporary relief of minor aches and pains of the muscles and joints, in addition to other inflammatory symptoms. Its pharmacological purpose includes relief of pain and inflammation generally, which covers joint discomfort.


Q: Is there a generic version of Psorimed available?

A: The active component in Psorimed, Sodium Salicylate, is a common, well-established compound. As a result, this ingredient is used in multiple generic and branded products, meaning various versions are available on the market.


Q: Can Psorimed affect fertility in men or women?

A: Official labeling for this drug class notes that NSAIDs are associated with reversible infertility. Official documents state that withdrawal of the drug should be considered for women who are having difficulties becoming pregnant.

How should Psorimed be stored and disposed of?

How to Store and Dispose of Psorimed: Official Regulatory Requirements

Storage of Psorimed (Sodium Salicylate liquid) must be maintained at Controlled Room Temperature, defined as 68 F to 77 F (20 C to 25 C). The product must be stored in its original container, which should be tight and light-resistant. It is mandatory that the liquid formulation not be frozen and that it be protected from excessive heat.

All medicines, including Psorimed, must be kept out of the sight and reach of children. Regarding disposal, the medicine should not be poured down the drain or into the toilet. Unused product should be disposed of via a drug take-back program or by securing it in the household trash according to official governmental guidelines.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Psorimed found in:

A-Z Index: